Tech Company Financing Transactions
Adarza BioSystems Funding Round
On 10/3/2014, Adarza BioSystems received $4 million in Series A funding from Cultivation Capital, Siemens Venture Capital and private investors.
Transaction Overview
Company Name
Announced On
10/3/2014
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Series A
Investors
Cultivation Capital (Lead Investor) (David Smoller)
Siemens Venture Capital (Lead Investor) (Ralf Schnell)
Proceeds Purpose
The latest financing is being used to launch the company's first 100-plex immunoassay product and accelerate development of highly sensitive plex assays that target biological analytes.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2184 Welsch Industrial Ct.
St. Louis, MO 63146
USA
St. Louis, MO 63146
USA
Phone
Website
Email Address
Overview
Adarza BioSystems develops a biological assay platform for measuring clinical and point-of-care samples.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bryan Witherbee
VP - Bus. Development
Linda Meeh
VP - Engineering
Jason Mitchell
VP - Engineering
Randy Motluck
VP - Engineering
Christopher Striemer
VP - Finance
Nakul Tandon
VP - Manufacturing
Bob Crepin
VP - R & D
Jon Schmuke
VP - Regulatory Affairs
Nannette Langevin
Browse more venture capital transactions:
Prev: 10/3/2014: Opal Labs venture capital transaction
Next: 10/3/2014: Physitrack venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs